A citation-based method for searching scientific literature

Amber Khan, David Leonard, Laura Defina, Carolyn E Barlow, Benjamin Willis, E Sherwood Brown. J Investig Med 2020
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
210
66


Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Sho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, Nobuyuki Horita, Masataka Wada, Sakiko Tsugawa, Eric Plitman, Yasunori Sano, Ryosuke Tarumi, Muhammad ElSalhy,[...]. Mol Psychiatry 2019
76
33

Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.
Brian A Hoshaw, Jessica E Malberg, Irwin Lucki. Brain Res 2005
252
33

Response to citalopram is not associated with SLC6A4 genotype in African-Americans and Caucasians with major depression.
Russell E Poland, Ira M Lesser, Yu-Jui Yvonne Wan, Lev Gertsik, Jie Yao, Leslie J Raffel, Keh-Ming Lin, Hector F Myers. Life Sci 2013
10
33

Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
Marcus Ising, Sonja Horstmann, Stefan Kloiber, Susanne Lucae, Elisabeth B Binder, Nikola Kern, Heike E Künzel, Andrea Pfennig, Manfred Uhr, Florian Holsboer. Biol Psychiatry 2007
244
33

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.
Sudeepa Bhattacharyya, Ahmed T Ahmed, Matthias Arnold, Duan Liu, Chunqiao Luo, Hongjie Zhu, Siamak Mahmoudiandehkordi, Drew Neavin, Gregory Louie, Boadie W Dunlop,[...]. Transl Psychiatry 2019
26
33

Brain 5-HT1 binding sites in depressed suicides.
S C Cheetham, M R Crompton, C L Katona, R W Horton. Psychopharmacology (Berl) 1990
137
33

Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.
P Zheng, J-J Chen, C-J Zhou, L Zeng, K-W Li, L Sun, M-L Liu, D Zhu, Z-H Liang, P Xie. Transl Psychiatry 2016
35
33

Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators.
Anderson Camargo, Ana Lúcia S Rodrigues. Chronic Stress (Thousand Oaks) 2019
11
33



A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment.
Marina Sagud, Matea Nikolac Perkovic, Bjanka Vuksan-Cusa, Anja Maravic, Dubravka Svob Strac, Alma Mihaljevic Peles, Maja Zivkovic, Zorana Kusevic, Nela Pivac. Psychopharmacology (Berl) 2016
17
33

Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.
Remmelt R Schür, Luc W R Draisma, Jannie P Wijnen, Marco P Boks, Martijn G J C Koevoets, Marian Joëls, Dennis W Klomp, René S Kahn, Christiaan H Vinkers. Hum Brain Mapp 2016
130
33



Analysis of 34 candidate genes in bupropion and placebo remission.
Arun K Tiwari, Clement C Zai, Gautam Sajeev, Tamara Arenovich, Daniel J Müller, James L Kennedy. Int J Neuropsychopharmacol 2013
28
33

Glycans - the third revolution in evolution.
Gordan Lauc, Jasminka Krištić, Vlatka Zoldoš. Front Genet 2014
37
33


The glucocorticoid receptor: pivot of depression and of antidepressant treatment?
Christoph Anacker, Patricia A Zunszain, Livia A Carvalho, Carmine M Pariante. Psychoneuroendocrinology 2011
343
33

Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.
Masaki Kato, Tsuyoshi Fukuda, Masataka Wakeno, Gaku Okugawa, Yoshiteru Takekita, Syunsuke Watanabe, Megumi Yamashita, Yuka Hosoi, Junichi Azuma, Toshihiko Kinoshita,[...]. Am J Med Genet B Neuropsychiatr Genet 2009
74
33

Interleukin, tumor necrosis factor-α and C-reactive protein profiles in melancholic and non-melancholic depression: A systematic review.
Chenghao Yang, Kim M Tiemessen, Fokko J Bosker, Klaas J Wardenaar, Jie Lie, Robert A Schoevers. J Psychosom Res 2018
18
33


Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine.
Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Ikuyo Motoki, Sumiko Tayoshi, Koshi Ohta, Hongwei Song, Kyoko Morita, Kazuhito Rokutan, Tetsuro Ohmori. Neurosci Lett 2005
46
33

Elevated IL-6 levels in patients with atypical depression but not in patients with typical depression.
Sebastian Rudolf, Wiebke Greggersen, Kai Gustav Kahl, Michael Hüppe, Ulrich Schweiger. Psychiatry Res 2014
46
33


Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression.
Raoul Belzeaux, Christine Formisano-Tréziny, Anderson Loundou, Laurent Boyer, Jean Gabert, Jean-Claude Samuelian, François Féron, Jean Naudin, El Chérif Ibrahim. J Psychiatr Res 2010
66
33

Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
Shih-Jen Tsai, Chen-Jee Hong, Ying-Jay Liou, Younger W-Y Yu, Tai-Jui Chen, Sheue-Jane Hou, Feng-Chang Yen. Prog Neuropsychopharmacol Biol Psychiatry 2009
69
33

d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
Danilo De Gregorio, Justine P Enns, Nicolas A Nuñez, Luca Posa, Gabriella Gobbi. Prog Brain Res 2018
27
33


Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study.
Jeffrey H Meyer, Heather E McNeely, Sandra Sagrati, Anahita Boovariwala, Krystle Martin, N Paul L G Verhoeff, Alan A Wilson, Sylvain Houle. Am J Psychiatry 2006
106
33

Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.
Sarah R Horn, Madison M Long, Benjamin W Nelson, Nicholas B Allen, Philip A Fisher, Michelle L Byrne. Brain Behav Immun 2018
52
33

Unraveling the Serum Metabolomic Profile of Post-partum Depression.
Zoe Papadopoulou, Angeliki-Maria Vlaikou, Daniela Theodoridou, Chrysoula Komini, Georgia Chalkiadaki, Marina Vafeiadi, Katerina Margetaki, Theoni Trangas, Chris W Turck, Maria Syrrou,[...]. Front Neurosci 2019
8
33


Comparison of acute treatment with delayed-onset versus rapid-acting antidepressants on effort-related choice behaviour.
Simonas Griesius, Jack R Mellor, Emma Sj Robinson. Psychopharmacology (Berl) 2020
1
100

The molecular perspective: tumor necrosis factor.
David S Goodsell. Oncologist 2006
10
33

Development of a non invasive NGF-based therapy for Alzheimer's disease.
Sonia Covaceuszach, Simona Capsoni, Gatsuella Ugolini, F Spirito, D Vignone, Antonio Cattaneo. Curr Alzheimer Res 2009
66
33

Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis.
Daiki Setoyama, Takahiro A Kato, Ryota Hashimoto, Hiroshi Kunugi, Kotaro Hattori, Kohei Hayakawa, Mina Sato-Kasai, Norihiro Shimokawa, Sachie Kaneko, Sumiko Yoshida,[...]. PLoS One 2016
55
33

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders.
Jian-Jun Chen, Shun-Jie Bai, Wen-Wen Li, Chan-Juan Zhou, Peng Zheng, Liang Fang, Hai-Yang Wang, Yi-Yun Liu, Peng Xie. Transl Psychiatry 2018
40
33

Prevalence of treatment-resistant depression in primary care: cross-sectional data.
Laura Thomas, David Kessler, John Campbell, Jill Morrison, Tim J Peters, Chris Williams, Glyn Lewis, Nicola Wiles. Br J Gen Pract 2013
63
33

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
Ari Illi, Eija Setälä-Soikkeli, Merja Viikki, Outi Poutanen, Heini Huhtala, Nina Mononen, Terho Lehtimäki, Esa Leinonen, Olli Kampman. Neuroreport 2009
93
33

Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression.
Gregory A Ordway, Jane Schenk, Craig A Stockmeier, Warren May, Violetta Klimek. Biol Psychiatry 2003
95
33


Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.
Kelly Doolin, Chloe Farrell, Leonardo Tozzi, Andrew Harkin, Thomas Frodl, Veronica O'Keane. Int J Mol Sci 2017
30
33

Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.
N Pivac, M Jakovljević, D Mück-Seler, Z Brzović. Psychiatry Res 1997
28
33

Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity.
Pooja Pallavi, Rajesh Sagar, Manju Mehta, Subhadra Sharma, Arulselvi Subramanium, Farah Shamshi, Utpal Sengupta, Rizwana Qadri, Ravindra M Pandey, Asok K Mukhopadhyay. J Affect Disord 2013
47
33

Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.
Danielle M Gerhard, Eric S Wohleb, Ronald S Duman. Drug Discov Today 2016
150
33


Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Xinyu Liu, Peng Zheng, Xinjie Zhao, Yuqing Zhang, Chunxiu Hu, Jia Li, Jieyu Zhao, Jingjing Zhou, Peng Xie, Guowang Xu. J Proteome Res 2015
97
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.